Central Trust Company’s Colgate-Palmolive CL Stock Holding History

Central Trust Company’s Portfolio CL Stock Details CL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$2.24M	Sell	26,269 -140	-0.5%	-$12.5K	0.04%	233
2025 Q4	$2.09M	Sell	26,409 -1,054	-4%	-$82.6K	0.04%	250
2025 Q3	$2.2M	Sell	27,463 -178	-0.6%	-$15.2K	0.05%	246
2025 Q2	$2.51M	Sell	27,641 -1,253	-4%	-$114K	0.06%	217
2025 Q1	$2.71M	Buy	28,894 +59	+0.2%	+$5.28K	0.07%	203
2024 Q4	$2.62M	Sell	28,835 -369	-1%	-$35.2K	0.06%	207
2024 Q3	$3.03M	Sell	29,204 -1,681	-5%	-$171K	0.07%	186
2024 Q2	$3M	Sell	30,885 -2,262	-7%	-$209K	0.07%	188
2024 Q1	$2.98M	Sell	33,147 -2,134	-6%	-$181K	0.07%	188
2023 Q4	$2.81M	Sell	35,281 -1,180	-3%	-$88.7K	0.07%	189
2023 Q3	$2.59M	Sell	36,461 -89	-0.2%	-$6.65K	0.07%	193
2023 Q2	$2.82M	Buy	36,550 +3,563	+11%	+$276K	0.08%	189
2023 Q1	$2.48M	Sell	32,987 -102	-0.3%	-$7.58K	0.07%	201
2022 Q4	$2.61M	Buy	33,089 +1,526	+5%	+$114K	0.08%	195
2022 Q3	$2.22M	Buy	31,563 +5,256	+20%	+$412K	0.08%	196
2022 Q2	$2.11M	Hold	26,307	–	–	0.07%	206
2022 Q1	$2M	Sell	26,307 -80	-0.3%	-$6.34K	0.06%	235
2021 Q4	$2.25M	Sell	26,387 -731	-3%	-$57.1K	0.06%	226
2021 Q3	$2.05M	Sell	27,118 -379	-1%	-$30.1K	0.07%	222
2021 Q2	$2.24M	Sell	27,497 -80	-0.3%	-$6.54K	0.08%	211
2021 Q1	$2.17M	Sell	27,577 -115	-0.4%	-$9.01K	0.09%	204
2020 Q4	$2.37M	Sell	27,692 -295	-1%	-$24.4K	0.1%	173
2020 Q3	$2.16M	Sell	27,987 -1,113	-4%	-$84.9K	0.1%	162
2020 Q2	$2.13M	Sell	29,100 -150	-0.5%	-$10.7K	0.11%	155
2020 Q1	$1.94M	Buy	29,250 +102	+0.3%	+$7.19K	0.12%	143
2019 Q4	$2.01M	Buy	29,148 +973	+3%	+$66.3K	0.1%	166
2019 Q3	$2.07M	Buy	28,175 +10	+0%	+$725	0.12%	154
2019 Q2	$2.08M	Sell	28,165 -15	-0.1%	-$1.06K	0.12%	156
2019 Q1	$1.93M	Sell	28,180 -665	-2%	-$43K	0.12%	158
2018 Q4	$1.72M	Hold	28,845	–	–	0.11%	166
2018 Q3	$1.93M	Sell	28,845 -4,458	-13%	-$297K	0.11%	174
2018 Q2	$2.16M	Buy	33,303 +398	+1%	+$26K	0.14%	151
2018 Q1	$2.36M	Buy	32,905 +342	+1%	+$24.6K	0.15%	141
2017 Q4	$2.46M	Sell	32,563 -218	-0.7%	-$15.9K	0.15%	134
2017 Q3	$2.39M	Sell	32,781 -253	-0.8%	-$18.2K	0.15%	135
2017 Q2	$2.45M	Sell	33,034 -577	-2%	-$42.8K	0.16%	138
2017 Q1	$2.46M	Sell	33,611 -370	-1%	-$25.9K	0.16%	139
2016 Q4	$2.22M	Buy	33,981 +6,977	+26%	+$478K	0.15%	150
2016 Q3	$2M	Buy	27,004 +141	+0.5%	+$10.4K	0.15%	150
2016 Q2	$1.97M	Sell	26,863 -25	-0.1%	-$1.78K	0.15%	148
2016 Q1	$1.9M	Sell	26,888 -4,223	-14%	-$281K	0.15%	144
2015 Q4	$2.07M	Buy	31,111 +3,272	+12%	+$218K	0.17%	131
2015 Q3	$1.77M	Sell	27,839 -3,681	-12%	-$240K	0.15%	140
2015 Q2	$2.06M	Sell	31,520 -700	-2%	-$47.5K	0.16%	138
2015 Q1	$2.23M	Buy	32,220 +279	+0.9%	+$19.3K	0.18%	127
2014 Q4	$2.21M	Sell	31,941 -4,350	-12%	-$294K	0.18%	130
2014 Q3	$2.37M	Buy	36,291 +79	+0.2%	+$5.21K	0.19%	129
2014 Q2	$2.47M	Sell	36,212 -325	-0.9%	-$21.8K	0.19%	128
2014 Q1	$2.37M	Buy	36,537 +75	+0.2%	+$4.73K	0.2%	122
2013 Q4	$2.38M	Buy	36,462 +50	+0.1%	+$3.2K	0.2%	119
2013 Q3	$2.16M	Buy	36,412 +2,894	+9%	+$171K	0.2%	118
2013 Q2	$1.92M	Buy	+33,518	New	+$1.99M	0.18%	123

Other funds holding CL

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

DAM

Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Central Trust Company's CL Position: Q1 2026 in Review

Central Trust Company reduced its Colgate-Palmolive (CL) stake by 0.53% in Q1 2026, selling an estimated $12.5K and leaving 26,269 shares worth $2.24M. The position accounts for 0.04% of the portfolio, ranked #233.

Central Trust Company first reported a position in CL in Q2 2013 and has held it in 52 quarters since. The position peaked at $3.03M in Q3 2024. 1,946 funds tracked by Wall St. Rank hold CL as of Q1 2026.

Central Trust Company held 26,269 shares of Colgate-Palmolive worth $2.24M as of Q1 2026.
Central Trust Company sold 140 Colgate-Palmolive shares in Q1 2026, an estimated $12.5K.
Colgate-Palmolive made up 0.04% of Central Trust Company's portfolio in Q1 2026, its #233 holding.
Central Trust Company first reported a position in Colgate-Palmolive in Q2 2013 and has held it in 52 quarters since.
Central Trust Company's Colgate-Palmolive position peaked at $3.03M in Q3 2024.
1,946 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q1 2026.

Based on Central Trust Company's 13F filing for Q1 2026, filed 17 Apr 2026.